Volume 21, Issue 6 (12-2018)                   J Arak Uni Med Sci 2018, 21(6): 107-118 | Back to browse issues page

XML Persian Abstract Print


1- Department of Exercise Physiology, Faculty of Physical Education and Sports Science, International Campus of Kharazmi University, Karaj, Iran.
2- Department of Exercise Physiology, Faculty of Physical Education and Sports Science, Kharazmi University, Karaj, Iran. , pezhman.motamedi@khu.ac.ir
3- Department of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak university of Medical Sciences, Arak, Iran.
4- Department of Exercise Physiology, Faculty of Physical Education and Sports Science, Kharazmi University, Karaj, Iran.
Abstract:   (2745 Views)
Background and Aim: Type 2 diabetes exerts an anti-angiogenesis effects on the cardiac tissue. The aim of present study was to investigate the effects of endurance training on gene expression of VEGF and VEGFR2 of cardiac tissue in type 2 diabetic male wistar rats.
Materials and Methods: 36 male wistar rats were randomly divided into three groups, Diabetic Endurance Training (DET), Diabetic Control (DC) and Healthy Control (HC). Type 2 diabetes was induced by intraperitoneal injection of STZ. The endurance training included 10 weeks, 5 sessions per week running at speed of 27 m/min and intensity of 75% VO2max for 20-30min in 1st week and reached to 27 m/min and intensity of 75% VO2max for 60 min/day in 10th weeks. The gene expression of VEGF and VEGFR2 were examined by Real-Time PCR AND Western Blotting.
Findings: The results of Real-Time PCR showed that the endurance training caused increase in VEGF mRNA (p<0.05) and VEGFR2 mRNA (p<0.05) compared to DC group. The results of Western Blotting also indicated that the endurance training induced increase in VEGF protein expression (p<0.05) compared to DC group and there was no significant change in expression of VEGFR2 protein (p>0.05).
Conclusion: Type 2 diabetes impairs the angiogenesis process in diabetic cardiac. It appears that endurance training has positive impact on angiogenesis and it can cause the improvement of diabetic cardiac.

 
Full-Text [PDF 2505 kb]   (1726 Downloads)    
Type of Study: Original Atricle | Subject: General
Received: 2018/04/4 | Accepted: 2018/07/24

References
1. Stamler J, Vaccaro O, Neaton JD, Wentworth D, Group MRFITR. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes care. 1993; 16(2):434-44.
2. Yoon Y-s, Uchida S, Masuo O, Cejna M, Park J-S, Gwon H-c, et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation. 2005; 111(16):2073-85.
3. Ingjer F. Effects of endurance training on muscle fibre ATP‐ase activity, capillary supply and mitochondrial content in man. The Journal of Physiology. 1979; 294(1):419-32.
4. Kota SK, Meher LK, Jammula S, Kota SK, Krishna S, Modi KD. Aberrant angiogenesis: The gateway to diabetic complications. Indian journal of endocrinology and metabolism. 2012; 16(6):918.
5. Egginton S. Invited review: activity-induced angiogenesis. Pflügers Archiv-European Journal of Physiology. 2009; 457(5):963.
6. Rundhaug JE. Matrix metalloproteinases and angiogenesis. Journal of cellular and molecular medicine. 2005; 9(2):267-85.
7. Way KL, Hackett DA, Baker MK, Johnson NA. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes & metabolism journal. 2016; 40(4):253-71.
8. Erekat NS, Al-Jarrah MD, Al Khatib AJ. Treadmill exercise training improves vascular endothelial growth Factor expression in the cardiac muscle of type I diabetic rats. Cardiology research. 2014; 5(1):23.
9. Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. Journal of the American College of Cardiology. 2005; 46(5):827-34.
10. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiological reviews. 2009; 89(2):607-48.
11. Zhao D, Tu Y, Wan L, Bu L, Huang T, Sun X, et al. In vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging. PloS one. 2013; 8(8): e71472.
12. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal of clinical oncology. 2005; 23(5):1011-27.
13. Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, et al. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes. 2004; 53(9):2383-91.
14. Sawada N, Arany Z. Metabolic regulation of angiogenesis in diabetes and aging. Physiology. 2017; 32(4):290-307.
15. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. The American journal of pathology. 1999; 154(2):355-63.
16. Tahergorabi Z, Khazaei M. Imbalance of angiogenesis in diabetic complications: the mechanisms. International journal of preventive medicine. 2012; 3(12):827.
17. Afzalpour ME, Chadorneshin HT, Foadoddini M, Eivari HA. Comparing interval and continuous exercise training regimens on neurotrophic factors in rat brain. Physiology & behavior. 2015; 147:78-83.
18. Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002; 51(4):1076-82.
19. Marfella R, Nappo F, De Angelis L, Paolisso G, Tagliamonte MR, Giugliano D. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care. 2000; 23(5):658-63.
20. Li S, Culver B, Ren J. Benefit and risk of exercise on myocardial function in diabetes. Pharmacological research. 2003; 48(2):127-32.
21. Czarkowska-Paczek B, Zendzian-Piotrowska M, Bartlomiejczyk I, Przybylski J, Gorski J. Skeletal and heart muscle expression of PDGF-AA and VEGF-A after an acute bout of exercise and endurance training in rats. Medical Science Monitor. 2010; 16(5):BR147-BR53.
22. Han B, Baliga R, Huang H, Giannone PJ, Bauer JA. Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 2009; 297(2):H829-H35.
23. Kraus RM, Stallings III HW, Yeager RC, Gavin TP. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. Journal of Applied Physiology. 2004; 96(4):1445-50.
24. Prior BM, Yang H, Terjung RL. What makes vessels grow with exercise training? Journal of applied physiology. 2004; 97(3):1119-28.
25. Warren CM, Ziyad S, Briot A, Der A, Iruela-Arispe ML. A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes. Sci Signal. 2014; 7(307):ra1-ra.
26. Khazaei M, Fallahzadeh AR, Sharifi MR, Afsharmoghaddam N, Javanmard SH, Salehi E. Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male rats. Clinics. 2011; 66(8):1419-24.
27. Dokun AO, Chen L, Lanjewar SS, Lye RJ, Annex BH. Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD. Cardiovascular research. 2014; 101(3):364-72.
28. Lee HJ. Exercise training regulates angiogenic gene expression in white adipose tissue. Journal of exercise rehabilitation. 2018; 14(1):16.
29. Kivelä R, Silvennoinen M, Lehti M, Jalava S, Vihko V, Kainulainen H. Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovascular diabetology. 2008; 7(1):13.
30. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature medicine. 2000; 6(9):1004.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.